Thigh magnetic resonance imaging for the evaluation of disease activity in patients with idiopathic inflammatory myopathies followed in a single center

Muscle and Nerve

Volumn 54, Issue 4, 2016, Pages 666-672

  Barsotti, Simone ^a,b   Zampa, Virna ^a   Talarico, Rosaria ^a   Minichilli, Fabrizio ^c   Ortori, Simona ^a   Iacopetti, Valentina ^a   D'ascanio, Anna ^a   Tavoni, Antonio Gaetano ^a   Bombardieri, Stefano ^a   Mosca, Marta ^a   Neri, Rossella ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

dermatomyositis; disease activity; idiopathic inflammatory myopathy; magnetic resonance imaging; MRI; myositis; polymyositis

Indexed keywords

CREATINE KINASE;

ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; CLINICAL EVALUATION; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE ASSESSMENT; EDEMA; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MANUAL MUSCLE TEST 8; MEDICAL RECORD REVIEW; MYOSITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PHYSICIAN GLOBAL ASSESSMENT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THIGH MUSCLE;

EID: 84986626780     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.25099     Document Type: Article

References (40)

1. Furst DE, Amato AA, Iorga ŞR, Gajria K, Fernandes AW. Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan. Muscle Nerve 2012;45:676–683.
2. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:971–982.
3. Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403–407.
4. Sontheimer RD Euwer RL, Costner MI. Dermatomyositis. In: Sontheimer RD, Provost TT, editors. Cutaneous manifestations of rheumatic diseases. Vol. 17. New York: Raven Press; 1973. p. 343–364.
5. Rider LG, Feldman BM, Perez MD, Rennebohm RM, Lindsley CB, Zemel LS, et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Arthritis Rheum 1997;40:1976–1983.
6. Rider LG, Koziol D, Giannini EH, Jain MS, Smith MR, Whitney-Mahoney K, et al. Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis Care Res 2010;62:465–472.
7. Alexanderson H, Del Grande M, Bingham CO III, Orbai A-M, Sarver C, Clegg-Smith K, et al. Patient-reported outcomes and adult patients' disease experience in the idiopathic inflammatory myopathies. Report from the OMERACT 11 Myositis Special Interest Group. J Rheumatol 2014;41:581–592.
8. Sultan SM, Allen E, Oddis CV, Kiely P, Cooper RG, Lundberg IE, et al. Reliability and validity of the myositis disease activity assessment tool. Arthritis Rheum 2008;58:3593–3599.
9. Pereira RMR, Freire de Carvalho J. Glucocorticoid-induced myopathy. Joint Bone Spine 2011;78:41–44.
10. Izumi Y, Miyashita T, Kitajima T, Yoshimura S, Takeoka A, Eguchi K, et al. Two cases of refractory polymyositis accompanied with steroid myopathy. Mod Rheumatol 2014;25:143–149.
11. Bronner IM, van der Meulen MFG, de Visser M, Kalmijn S, van Venrooij WJ, Voskuyl AE, et al. Long-term outcome in polymyositis and dermatomyositis. Ann Rheum Dis 2006;65:1456–1461.
12. Wong EH, Hui ACF, Griffith JF, Wong SM, Szeto CC. MRI in biopsy-negative dermatomyositis. Neurology 2005;64:750.
13. Pitt AM, Fleckenstein JL, Greenlee RG Jr, Burns DK, Bryan WW, Haller R. MRI-guided biopsy in inflammatory myopathy: initial results. Magn Reson Imaging 1993;11:1093–1099.
14. Ladd PE, Emery KH, Salisbury SR, Laor T, Lovell DJ, Bove KE. Juvenile dermatomyositis: correlation of MRI at presentation with clinical outcome. AJR Am J Roentgenol 2011;197:W153–158.
15. Maillard SM, Jones R, Owens C, Pilkington C, Woo P, Wedderburn LR, et al. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology 2004;43:603–608.
16. Malattia C, Damasio MB, Madeo A, Pistorio A, Providenti A, Pederzoli S, et al. Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis. Ann Rheum Dis 2013;73:1083–1090
17. Adams EM, Chow CK, Premkumar A, Plotz PH. The idiopathic inflammatory myopathies: spectrum of MR imaging findings. Radiogr Rev Publ Radiol Soc N Am Inc 1995;15:563–574.
18. Yoshida K, Kurosaka D, Joh K, Matsushima S, Takahashi E, Hirai K, et al. Fasciitis as a common lesion of dermatomyositis, demonstrated early after disease onset by en bloc biopsy combined with magnetic resonance imaging. Arthritis Rheum 2010;62:3751–3759.
19. Hernandez RJ, Keim DR, Chenevert TL, Sullivan DB, Aisen AM. Fat-suppressed MR imaging of myositis. Radiology 1992;182:217–219.
20. Baur A, Reiser MF. Diffusion-weighted imaging of the musculoskeletal system in humans. Skeletal Radiol 2000;29:555–562.
21. Harish S, Chiavaras MM, Kotnis N, Rebello R. MR imaging of skeletal soft tissue infection: utility of diffusion-weighted imaging in detecting abscess formation. Skeletal Radiol 2011;40:285–294.
22. Bley TA, Wieben O, Uhl M. Diffusion-weighted MR imaging in musculoskeletal radiology: applications in trauma, tumors, and inflammation. Magn Reson Imaging Clin N Am 2009;17:263–275.
23. Qi J, Olsen NJ, Price RR, Winston JA, Park JH. Diffusion-weighted imaging of inflammatory myopathies: polymyositis and dermatomyositis. J Magn Reson Imaging 2008;27:212–217.
24. Koenker R. Quantile regression. New York: Cambridge University Press; 2005.
25. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121–130.
26. Fraser DD, Frank JA, Dalakas M, Miller FW, Hicks JE, Plotz P. Magnetic resonance imaging in the idiopathic inflammatory myopathies. J Rheumatol 1991;18:1693–1700.
27. Kuo GP, Carrino JA. Skeletal muscle imaging and inflammatory myopathies. Curr Opin Rheumatol 2007;19:530–535.
28. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, et al. 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 2004;14:337–345.
29. Dion E, Cherin P, Payan C, Fournet J-C, Papo T, Maisonobe T, et al. Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis. J Rheumatol 2002;29:1897–1906.
30. Lampa J, Nennesmo I, Einarsdottir H, Lundberg I. MRI guided muscle biopsy confirmed polymyositis diagnosis in a patient with interstitial lung disease. Ann Rheum Dis 2001;60:423–426.
31. van de Vlekkert J, Maas M, Hoogendijk JE, de Visser M, van Schaik IN. Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy. Muscle Nerve 2015;51:253–258.
32. Bartlett ML, Ginn L, Beitz L, Villalba ML, Plotz P, Bacharach SL. Quantitative assessment of myositis in thigh muscles using magnetic resonance imaging. Magn Reson Imaging 1999;17:183–191.
33. Tomasová Studynková J, Charvát F, Jarosová K, Vencovsky J. The role of MRI in the assessment of polymyositis and dermatomyositis. Rheumatology 2007;46:1174–1179.
34. Kimball AB, Summers RM, Turner M, Dugan EM, Hicks J, Miller FW, et al. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy. Arthritis Rheum 2000;43:1866–1873.
35. Davis WR, Halls JE, Offiah AC, Pilkington C, Owens CM, Rosendahl K. Assessment of active inflammation in juvenile dermatomyositis: a novel magnetic resonance imaging-based scoring system. Rheumatology 2011;50:2237–2244.
36. Ringleb SI, Bensamoun SF, Chen Q, Manduca A, An K-N, Ehman RL. Applications of magnetic resonance elastography to healthy and pathologic skeletal muscle. J Magn Reson Imaging 2007;25:301–309.
37. McCullough MB, Domire ZJ, Reed AM, Amin S, Ytterberg SR, Chen Q, et al. Evaluation of muscles affected by myositis using magnetic resonance elastography. Muscle Nerve 2011;43:585–590.
38. Park JH, Vital TL, Ryder NM, Hernanz-Schulman M, Partain CL, Price RR, et al. Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis. Arthritis Rheum 1994;37:736–746.
39. Cea G, Bendahan D, Manners D, Hilton-Jones D, Lodi R, Styles P, et al. Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: a quantitative 31P-magnetic resonance spectroscopy and MRI study. Brain J Neurol 2002;125:1635–1645.
40. Subhawong TK, Wang X, Machado AJ, Mammen AL, Christopher-Stine L, Barker PB, et al. 1H Magnetic resonance spectroscopy findings in idiopathic inflammatory myopathies at 3 T: feasibility and first results. Invest Radiol 2013;48:509–516.